RT Journal Article
T1 Renal denervation for the treatment of resistant hypertension in Spain. The Flex-Spyral Registry.
A1 Rodriguez-Leor, Oriol
A1 Segura, Julián
A1 García Donaire, José Antonio
A1 Gutiérrez-Ibañes, Enrique
A1 Oliveras, Anna
A1 Mediavilla, Juan Diego
A1 Serrador, Ana
A1 Prado, José Carlos
A1 Nuñez-Gil, Iván
A1 Díez-Delhoyo, Felipe
A1 Clarà Velasco, Albert
A1 Jaén Águila, Fernando
A1 Amat-Santos, Ignacio
A1 Bayes-Genis, Antoni
A1 Troya Saborido, María Isabel
K1 Blood pressure
K1 Denervación renal percutánea
K1 Hipertensión arterial
K1 Hypertension
K1 Percutaneous renal denervation
K1 Presión arterial
K1 Sistema nervioso simpático
K1 Sympathetic nervous system
AB Renal denervation is a percutaneous intervention for the treatment of resistant hypertension. Randomized studies have shown contradictory results on its efficacy. We present the results of a renal denervation registry for the treatment of resistant hypertension in real-life patients in Spain. Multicenter registry of consecutive patients with resistant hypertension treated with renal denervation in Spain between 2009 and 2018. We included 125 patients (mean age, 56 years; 41% female; mean onset of hypertension 14±9 years previously). Office systolic and diastolic blood pressure and ambulatory blood pressure monitoring decreased 6 months after the intervention (166±20/95±16 to 149±22/87±16 mmHg and 151±14/89±12 to 143±15/84±11, both P  In patients with resistant hypertension, treatment with renal denervation was related to a decrease in office blood pressure and, more importantly, in ambulatory blood pressure monitoring, with a significant reduction in pharmacological treatment.
YR 2019
FD 2019-09-24
LK http://hdl.handle.net/10668/14562
UL http://hdl.handle.net/10668/14562
LA en
LA es
DS RISalud
RD Apr 11, 2025